Variability in response to aspirin: do we understand the clinical relevance?
- 1 April 2005
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 3 (4) , 665-669
- https://doi.org/10.1111/j.1538-7836.2005.01119.x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatmentJournal of the American College of Cardiology, 2004
- Functional and Biochemical Evaluation of Platelet Aspirin Resistance After Coronary Artery Bypass SurgeryCirculation, 2003
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey.The American Journal of Cardiology, 1999
- Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistanceThe Lancet, 1999
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- Development of aspirin resistance in persons with previous ischemic stroke.Stroke, 1994
- Clinical pharmacology of platelet cyclooxygenase inhibition.Circulation, 1985
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- Inhibition of platelet prostaglandin synthetase by oral aspirin.Journal of Clinical Investigation, 1978